Saturday, April 18, 2026

#gene therapy

4 articles

Clinical-Stage Biotech Secures Capital Through Private Placements as Phase 2/3 Trials Advance in Ophthalmology and KRAS-Targeted Oncology

Healthcare & Life Sciences Investment

Clinical-Stage Biotech Secures Capital Through Private Placements as Phase 2/3 Trials Advance in Ophthalmology and KRAS-Targeted Oncology

Salvado•Mar 26, 2026

Biotech Companies Report Clinical Progress in AI-Assisted Drug Development Programs

Biotech Investment

Biotech Companies Report Clinical Progress in AI-Assisted Drug Development Programs

Salvado•Mar 24, 2026

Biotech's Commercial Inflection: What the Gene Therapy and mRNA Pipeline Surge Means for Investors

Healthcare Finance

Biotech's Commercial Inflection: What the Gene Therapy and mRNA Pipeline Surge Means for Investors

ViaNews Editorial Team (Finance)•Feb 18, 2026

REGENXBIO Eyes 2027 Commercial Launch for Duchenne Gene Therapy as Pivotal Trial Wraps Enrollment

Biotech & Pharmaceuticals

REGENXBIO Eyes 2027 Commercial Launch for Duchenne Gene Therapy as Pivotal Trial Wraps Enrollment

ViaNews Editorial Team (Finance)•Feb 18, 2026